InsiderTrades.com logo

SHPH Insider Trading

Insider Ownership Percentage: 12.60%
Insider Buying (Last 12 Months): $110,694.49
Insider Selling (Last 12 Months): $0.00

Shuttle Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Shuttle Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Shuttle Pharmaceuticals Share Price & Price History

Current Price: $3.40
Price Change: ▲ Price Increase of +0.15 (4.62%)
As of 07/1/2026 04:00 PM ET

This chart shows the closing price history over time for SHPH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Shuttle Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/30/2026Financial Lp HrtMajor ShareholderBuy6,755$3.23$21,818.6578,597View SEC Filing Icon  
6/29/2026Financial Lp HrtMajor ShareholderBuy25,836$3.44$88,875.8471,842View SEC Filing Icon  
12/13/2023Bette JacobsDirectorSell16$115.00$1,840.00108View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Shuttle Pharmaceuticals (NASDAQ:SHPH)

4.58% of Shuttle Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SHPH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Shuttle Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC68,993$0.12M0.0%N/A4.312%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC20,360$37K0.0%N/A1.273%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC14,444$26K0.0%N/A0.903%Search for SEC Filing on Google Icon
11/17/2025Connective Capital Management LLC100,535$0.36M0.3%N/A9.396%Search for SEC Filing on Google Icon
5/15/2025Armistice Capital LLC70,399$27K0.0%-77.0%1.125%Search for SEC Filing on Google Icon
2/2/2023SG Americas Securities LLC16,899$33K0.0%N/A0.124%Search for SEC Filing on Google Icon
11/14/2022Hsbc Holdings PLC13,737$67K0.0%N/A0.103%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC17,048$78K0.0%N/A0.128%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Shuttle Pharmaceuticals logo
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers . The company is based in Gaithersburg, Maryland.
Read More on Shuttle Pharmaceuticals

Today's Range

Now: $3.40
Low: $3.05
High: $3.49

50 Day Range

MA: $5.93
Low: $3.25
High: $10.50

52 Week Range

Now: $3.40
Low: $2.90
High: $55.90

Volume

169,219 shs

Average Volume

2,351,062 shs

Market Capitalization

$2.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.29

Who are the company insiders with the largest holdings of Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals' top insider shareholders include:
  1. Financial Lp Hrt (Major Shareholder)
  2. Bette Jacobs (Director)
  3. Peter Dritschilo (COO)
  4. Hoek Michael Vander (CFO)
Learn More about top insider investors at Shuttle Pharmaceuticals.